Integra LifeSciences (NASDAQ:IART) Price Target Raised to $11.00 at Citigroup
Integra LifeSciences (NASDAQ:IART – Get Free Report) had its price objective raised by analysts at Citigroup from $9.00 to $11.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “sell” rating on the life sciences company’s stock. Citigroup’s price target would indicate a potential downside of 21.33% [...]